KEGG Orthology (KO) - Pan troglodytes (chimpanzee)

[ Brite menu | Organism menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level 

     KO
 Metabolism
 
   Overview
 
   Carbohydrate metabolism
 
   Energy metabolism
 
   Lipid metabolism
     00061 Fatty acid biosynthesis [PATH:ptr00061]
     00062 Fatty acid elongation [PATH:ptr00062]
     00071 Fatty acid degradation [PATH:ptr00071]
     00072 Synthesis and degradation of ketone bodies [PATH:ptr00072]
     00073 Cutin, suberine and wax biosynthesis
     00100 Steroid biosynthesis [PATH:ptr00100]
     00120 Primary bile acid biosynthesis [PATH:ptr00120]
     00121 Secondary bile acid biosynthesis
     00140 Steroid hormone biosynthesis [PATH:ptr00140]
     00561 Glycerolipid metabolism [PATH:ptr00561]
     00564 Glycerophospholipid metabolism [PATH:ptr00564]
     00565 Ether lipid metabolism [PATH:ptr00565]
     00600 Sphingolipid metabolism [PATH:ptr00600]
     00590 Arachidonic acid metabolism [PATH:ptr00590]
       748864 PLA2G2E; phospholipase A2, group IIE
       748868 PLA2G2F; phospholipase A2, group IIF
       469200 PLA2G2D; phospholipase A2, group IID
       466292 PLA2G12B; phospholipase A2, group XIIB
       740803 PLA2G10; phospholipase A2, group X
       456587 PLA2G2A; phospholipase A2, group IIA (platelets, synovial fluid)
       456588 PLA2G5; phospholipase A2, group V
       470183 PLA2G3; phospholipase A2, group III
       742280 PLA2G1B; phospholipase A2, group IB (pancreas)
       736845 PLA2G12A; phospholipase A2, group XIIA
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       470208 PLA2G6; phospholipase A2, group VI (cytosolic, calcium-independent)
       459117 PLB1; phospholipase B1
       451279 PLA2G16; phospholipase A2, group XVI
       464713 PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       473071 PTGES; prostaglandin E synthase
       464763 PTGES2; prostaglandin E synthase 2 
       746021 PTGES3; prostaglandin E synthase 3 (cytosolic) 
       473983 CBR1; carbonyl reductase 1
       458533 CBR3; carbonyl reductase 3
       744202 FAM213B; family with sequence similarity 213, member B
       463774 TBXAS1; thromboxane A synthase 1 (platelet)
       743219 HPGDS; hematopoietic prostaglandin D synthase
       749402 PTGDS; prostaglandin D2 synthase 21kDa (brain)
       100612718 AKR1C3; aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)
       458323 PTGIS; prostaglandin I2 (prostacyclin) synthase
       450428 ALOX5; arachidonate 5-lipoxygenase
       452145 LTA4H; leukotriene A4 hydrolase 
       748117 leukotriene-B(4) omega-hydroxylase 2-like
       748531 leukotriene-B(4) omega-hydroxylase 2-like
       739986 LTC4S; leukotriene C4 synthase
       470168 GGT1; gamma-glutamyltransferase 1
       458711 GGT5; gamma-glutamyltransferase 5 
       469325 GPX7; glutathione peroxidase 7 
       461015 GPX1; glutathione peroxidase 1 
       471920 GPX6; glutathione peroxidase 6 (olfactory) 
       471703 GPX3; glutathione peroxidase 3 (plasma) 
       467483 GPX2; glutathione peroxidase 2 (gastrointestinal) 
       461872 GPX8; glutathione peroxidase 8 (putative) 
       450857 cytochrome P450 2E1-like
       456896 cytochrome P450 2J2-like
       471267 cytochrome P450 2U1-like
       739864 cytochrome P450 4A11-like
       740956 cytochrome P450 2C19-like
       748442 cytochrome P450 4F8-like
       455242 ALOX12; arachidonate 12-lipoxygenase
       455243 arachidonate 12-lipoxygenase
       455103 ALOX12B; arachidonate 12-lipoxygenase, 12R type
       455104 ALOX15B; arachidonate 15-lipoxygenase, type B
       456052 cytochrome P450 2B6-like
       450909 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8
       100616515 cytochrome P450 2C9-like
       464074 EPHX2; epoxide hydrolase 2, cytoplasmic
       748294 ALOX15; arachidonate 15-lipoxygenase
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K01047 PLA2G; secretory phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16343 PLA2G6; calcium-independent phospholipase A2 [EC:3.1.1.4]
K14621 PLB1; phospholipase B1, membrane-associated [EC:3.1.1.4 3.1.1.5]
K16817 PLA2G16; HRAS-like suppressor 3 [EC:3.1.1.32 3.1.1.4]
K00509 PTGS1; prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K15729 PTGES; microsomal prostaglandin-E synthase 1 [EC:5.3.99.3]
K05309 PTGES2; microsomal prostaglandin-E synthase 2 [EC:5.3.99.3]
K15730 PTGES3; cytosolic prostaglandin-E synthase [EC:5.3.99.3]
K00079 CBR1; carbonyl reductase 1 [EC:1.1.1.184 1.1.1.189 1.1.1.197]
K00084 CBR3; carbonyl reductase 3 [EC:1.1.1.184]
K15717 K15717; prostamide/prostaglandin F2alpha synthase [EC:1.11.1.20]
K01832 TBXAS1; thromboxane-A synthase [EC:5.3.99.5]
K01830 E5.3.99.2; prostaglandin-H2 D-isomerase [EC:5.3.99.2]
K01830 E5.3.99.2; prostaglandin-H2 D-isomerase [EC:5.3.99.2]
K04119 AKR1C3; aldo-keto reductase family 1 member C3 [EC:1.1.1.64 1.1.1.188 1.1.1.213]
K01831 PTGIS; prostacyclin synthase [EC:5.3.99.4]
K00461 ALOX5; arachidonate 5-lipoxygenase [EC:1.13.11.34]
K01254 LTA4H; leukotriene-A4 hydrolase [EC:3.3.2.6]
K17726 CYP4F2_3; leukotriene-B4 20-monooxygenase / phylloquinone omega-hydroxylase [EC:1.14.13.30 1.14.13.194]
K17726 CYP4F2_3; leukotriene-B4 20-monooxygenase / phylloquinone omega-hydroxylase [EC:1.14.13.30 1.14.13.194]
K00807 LTC4S; leukotriene-C4 synthase [EC:4.4.1.20]
K18592 GGT1_5; gamma-glutamyltranspeptidase / glutathione hydrolase / leukotriene-C4 hydrolase [EC:2.3.2.2 3.4.19.13 3.4.19.14]
K18592 GGT1_5; gamma-glutamyltranspeptidase / glutathione hydrolase / leukotriene-C4 hydrolase [EC:2.3.2.2 3.4.19.13 3.4.19.14]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K00432 E1.11.1.9; glutathione peroxidase [EC:1.11.1.9]
K07415 CYP2E1; cytochrome P450, family 2, subfamily E, polypeptide 1 [EC:1.14.13.-]
K07418 CYP2J; cytochrome P450, family 2, subfamily J [EC:1.14.14.1]
K07422 CYP2U1; cytochrome P450, family 2, subfamily U, polypeptide 1
K07425 CYP4A; alkane 1-monooxygenase [EC:1.14.15.3]
K17721 CYP2C19; cytochrome P450, family 2, subfamily C, polypeptide 19 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17728 CYP4F8; cytochrome P450, family 4, subfamily F, polypeptide 8 [EC:1.14.14.1]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K08021 ALOX12B; arachidonate 12-lipoxygenase (R-type) [EC:1.13.11.-]
K08022 ALOX15B; arachidonate 15-lipoxygenase (second type) / 8-lipoxygenase (S-type) [EC:1.13.11.33 1.13.11.-]
K17709 CYP2B6; cytochrome P450, family 2, subfamily B, polypeptide 6 [EC:1.14.13.-]
K17718 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8 [EC:1.14.14.1]
K17719 CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K08726 EPHX2; soluble epoxide hydrolase / lipid-phosphate phosphatase [EC:3.3.2.10 3.1.3.76]
K00460 ALOX15; arachidonate 15-lipoxygenase [EC:1.13.11.33]
     00591 Linoleic acid metabolism [PATH:ptr00591]
     00592 alpha-Linolenic acid metabolism [PATH:ptr00592]
     01040 Biosynthesis of unsaturated fatty acids [PATH:ptr01040]
     01004 Lipid biosynthesis proteins [BR:ptr01004]
 
   Nucleotide metabolism
 
   Amino acid metabolism
 
   Metabolism of other amino acids
 
   Glycan biosynthesis and metabolism
 
   Metabolism of cofactors and vitamins
 
   Metabolism of terpenoids and polyketides
 
   Biosynthesis of other secondary metabolites
 
   Xenobiotics biodegradation and metabolism
 
   Enzyme families
 
 Genetic Information Processing
 
 Environmental Information Processing
 
 Cellular Processes
 
 Organismal Systems
 
   Immune system
     04640 Hematopoietic cell lineage [PATH:ptr04640]
     04610 Complement and coagulation cascades [PATH:ptr04610]
     04611 Platelet activation [PATH:ptr04611]
       468667 TBXA2R; thromboxane A2 receptor
       471510 F2R; coagulation factor II (thrombin) receptor
       455829 F2RL3; coagulation factor II (thrombin) receptor-like 3
       454827 GNA13; guanine nucleotide binding protein (G protein), alpha 13
       456067 ARHGEF1; Rho guanine nucleotide exchange factor (GEF) 1
       451618 ARHGEF12; Rho guanine nucleotide exchange factor (GEF) 12
       461014 RHOA; ras homolog family member A
       455326 ROCK1; Rho-associated, coiled-coil containing protein kinase 1
       470307 ROCK2; Rho-associated, coiled-coil containing protein kinase 2
       462795 PPP1CC; protein phosphatase 1, catalytic subunit, gamma isoform
       745709 PPP1CA; protein phosphatase 1, catalytic subunit, alpha isozyme
       743656 PPP1CC; protein phosphatase 1, catalytic subunit, gamma isoform
       459118 PPP1CB; protein phosphatase 1, catalytic subunit, beta isozyme
       452095 PPP1R12A; protein phosphatase 1, regulatory subunit 12A
       455313 MYL12B; myosin, light chain 12B, regulatory
       455314 MYL12A; myosin, light chain 12A, regulatory, non-sarcomeric
       454439 P2RX1; purinergic receptor P2X, ligand-gated ion channel, 1
       473293 ORAI1; ORAI calcium release-activated calcium modulator 1
       460134 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       473389 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       462618 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       450973 STIM1; stromal interaction molecule 1
       460640 MYLK; myosin light chain kinase
       742591 MYLK2; myosin light chain kinase 2
       465143 MYLK3; myosin light chain kinase 3
       471840 MYLK4; myosin light chain kinase family, member 4
       101057233 MYLK; myosin light chain kinase
       470970 P2RY1; purinergic receptor P2Y, G-protein coupled, 1
       472962 GNAQ; guanine nucleotide binding protein (G protein), q polypeptide
       453330 PLCB2; phospholipase C, beta 2
       458093 PLCB4; phospholipase C, beta 4
       469875 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific)
       451290 PLCB3; phospholipase C, beta 3 (phosphatidylinositol-specific)
       450143 PRKCI; protein kinase C, iota
       743533 PRKCZ; protein kinase C, zeta
       453316 RASGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated)
       451298 RASGRP2; RAS guanyl releasing protein 2 (calcium and DAG-regulated)
       469408 RAP1A; RAP1A, member of RAS oncogene family
       452065 RAP1B; RAP1B, member of RAS oncogene family
       450361 APBB1IP; amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
       453494 TLN2; talin 2
       465080 TLN1; talin 1
       454730 ITGA2B; integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
       468295 ITGB3; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
       451287 FERMT3; fermitin family member 3
       461559 FGA; fibrinogen alpha chain
       461558 FGB; fibrinogen beta chain
       461560 FGG; fibrinogen gamma chain
       738917 P2RY12; purinergic receptor P2Y, G-protein coupled, 12
       457093 GNAI3; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
       472425 GNAI1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
       744773 GNAI2; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
       463392 ADCY1; adenylate cyclase 1 (brain)
       461715 ADCY2; adenylate cyclase 2
       459070 ADCY3; adenylate cyclase 3
       452819 ADCY4; adenylate cyclase 4
       470905 ADCY5; adenylate cyclase 5
       451866 ADCY6; adenylate cyclase 6
       473278 ADCY7; adenylate cyclase 7
       464400 ADCY8; adenylate cyclase 8 (brain)
       100615296 adenylate cyclase type 8-like
       453869 ADCY9; adenylate cyclase 9
       456154 PTGIR; prostaglandin I2 (prostacyclin) receptor (IP)
       469986 GNAS; GNAS complex locus
       463649 PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
       460858 PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
       457922 PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
       471079 PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
       456565 PIK3R3; phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
       461836 PIK3R1; phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
       455085 PIK3R5; phosphoinositide-3-kinase, regulatory subunit 5
       455855 PIK3R2; phosphoinositide-3-kinase, regulatory subunit 2 (beta)
       469367 PRKACB; protein kinase, cAMP-dependent, catalytic, beta
       472944 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma
       449495 PRKX; protein kinase, X-linked 
       455776 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha
       751063 cAMP-dependent protein kinase catalytic subunit PRKX-like
       450133 ACTB; actin, beta
       744996 actin
       746570 ACTG1; actin, gamma 1
       458229 SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
       456157 ARHGAP35; Rho GTPase activating protein 35
       450194 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32)
       464586 SYK; spleen tyrosine kinase
       455117 COL1A1; collagen, type I, alpha 1
       459815 COL3A1; collagen, type III, alpha 1
       463542 COL1A2; collagen, type I, alpha 2
       451860 COL2A1; collagen, type II, alpha 1
       459817 COL5A2; collagen, type V, alpha 2
       457065 COL11A1; collagen, type XI, alpha 1
       462600 COL11A2; collagen, type XI, alpha 2
       464681 COL27A1; collagen, type XXVII, alpha 1
       455692 COL5A3; collagen, type V, alpha 3
       456990 COL24A1; collagen, type XXIV, alpha 1
       456429 GP6; glycoprotein VI (platelet)
       100612300 FCER1G; Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
       472771 LYN; v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
       462944 FYN; FYN oncogene related to SRC, FGR, YES
       471550 ITGA2; integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
       450396 ITGB1; integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
       471734 LCP2; lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
       454268 PLCG2; phospholipase C, gamma 2 (phosphatidylinositol-specific)
       465759 BTK; Bruton agammaglobulinemia tyrosine kinase
       451773 VWF; von Willebrand factor
       741837 GP5; glycoprotein V (platelet)
       468166 GP1BA; glycoprotein Ib (platelet), alpha polypeptide
       737968 GP9; glycoprotein IX (platelet)
       456035 AKT2; v-akt murine thymoma viral oncogene homolog 2
       740898 AKT1; v-akt murine thymoma viral oncogene homolog 1
       100609583 AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) 
       463893 NOS3; nitric oxide synthase 3 (endothelial cell)
       466769 GUCY1A2; guanylate cyclase 1, soluble, alpha 2
       100608597 GUCY1A3; guanylate cyclase 1, soluble, alpha 3
       452727 GUCY1B2; guanylate cyclase soluble subunit beta-2-like
       461565 GUCY1B3; guanylate cyclase 1, soluble, beta 3
       461217 PRKG2; protein kinase, cGMP-dependent, type II
       744467 PRKG1; protein kinase, cGMP-dependent, type I
       450161 MAPK14; mitogen-activated protein kinase 14 
       462644 MAPK13; mitogen-activated protein kinase 13 
       747077 MAPK12; mitogen-activated protein kinase 12
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       464713 PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
       463774 TBXAS1; thromboxane A synthase 1 (platelet)
       453365 SNAP23; synaptosomal-associated protein, 23kDa
       459365 VAMP8; vesicle-associated membrane protein 8
K04264 TBXA2R; thromboxane A2 receptor
K03914 F2R; coagulation factor II (thrombin) receptor
K04236 F2RL3; coagulation factor II (thrombin) receptor-like 3
K04639 GNA13; guanine nucleotide-binding protein subunit alpha-13
K12330 ARHGEF1; Rho guanine nucleotide exchange factor 1
K07532 ARHGEF12; Rho guanine nucleotide exchange factor 12
K04513 RHOA; Ras homolog gene family, member A
K04514 ROCK1; Rho-associated protein kinase 1 [EC:2.7.11.1]
K17388 ROCK2; Rho-associated protein kinase 2 [EC:2.7.11.1]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06269 PPP1C; serine/threonine-protein phosphatase PP1 catalytic subunit [EC:3.1.3.16]
K06270 PPP1R12A; protein phosphatase 1 regulatory subunit 12A
K12757 MYL12; myosin regulatory light chain 12
K12757 MYL12; myosin regulatory light chain 12
K05215 P2RX1; P2X purinoceptor 1
K16056 ORAI1; calcium release-activated calcium channel protein 1
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K16059 STIM1; stromal interaction molecule 1
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K00907 MYLK; myosin-light-chain kinase [EC:2.7.11.18]
K04270 P2RY1; purinergic receptor P2Y, G protein-coupled, 1
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K06069 APKC; atypical protein kinase C [EC:2.7.11.13]
K06069 APKC; atypical protein kinase C [EC:2.7.11.13]
K04350 RASGRP1; RAS guanyl-releasing protein 1
K12361 RASGRP2; RAS guanyl-releasing protein 2
K04353 RAP1A; Ras-related protein Rap-1A
K07836 RAP1B; Ras-related protein Rap-1B
K17704 APBB1IP; amyloid beta A4 precursor protein-binding family B member 1-interacting protein
K06271 TLN; talin
K06271 TLN; talin
K06476 ITGA2B; integrin alpha 2B
K06493 ITGB3; integrin beta 3
K17084 FERMT3; kindlin 3
K03903 FGA; fibrinogen alpha chain
K03904 FGB; fibrinogen beta chain
K03905 FGG; fibrinogen gamma chain
K04298 P2RY12; purinergic receptor P2Y, G protein-coupled, 12
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K08041 ADCY1; adenylate cyclase 1 [EC:4.6.1.1]
K08042 ADCY2; adenylate cyclase 2 [EC:4.6.1.1]
K08043 ADCY3; adenylate cyclase 3 [EC:4.6.1.1]
K08044 ADCY4; adenylate cyclase 4 [EC:4.6.1.1]
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K08046 ADCY6; adenylate cyclase 6 [EC:4.6.1.1]
K08047 ADCY7; adenylate cyclase 7 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08048 ADCY8; adenylate cyclase 8 [EC:4.6.1.1]
K08049 ADCY9; adenylate cyclase 9 [EC:4.6.1.1]
K04263 PTGIR; prostacyclin receptor
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K00922 PIK3C; phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K02649 PIK3R; phosphoinositide-3-kinase, regulatory subunit
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K05692 ACTB_G1; actin beta/gamma 1
K05704 SRC; tyrosine-protein kinase Src [EC:2.7.10.2]
K05732 GRLF1; glucocorticoid receptor DNA-binding factor 1
K06472 FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a
K05855 SYK; spleen tyrosine kinase [EC:2.7.10.2]
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06236 COL1AS; collagen, type I/II/III/V/XI/XXIV/XXVII, alpha
K06264 GP6; platelet glycoprotein VI
K07983 FCER1G; Fc receptor, IgE, high affinity I, gamma polypeptide
K05854 LYN; tyrosine-protein kinase Lyn [EC:2.7.10.2]
K05703 FYN; tyrosine-protein kinase Fyn [EC:2.7.10.2]
K06481 ITGA2; integrin alpha 2
K05719 ITGB1; integrin beta 1
K07361 LCP2; lymphocyte cytosolic protein 2
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11]
K07370 BTK; Bruton agammaglobulinemia tyrosine kinase [EC:2.7.10.2]
K03900 VWF; von Willebrand factor
K06260 GP5; platelet glycoprotein V
K06261 GP1BA; platelet glycoprotein Ib alpha chain
K06263 GP9; platelet glycoprotein IX
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K04456 AKT; RAC serine/threonine-protein kinase [EC:2.7.11.1]
K13242 NOS3; nitric-oxide synthase, endothelial [EC:1.14.13.39]
K12318 GUCY1A; guanylate cyclase soluble subunit alpha [EC:4.6.1.2]
K12318 GUCY1A; guanylate cyclase soluble subunit alpha [EC:4.6.1.2]
K12319 GUCY1B; guanylate cyclase soluble subunit beta [EC:4.6.1.2]
K12319 GUCY1B; guanylate cyclase soluble subunit beta [EC:4.6.1.2]
K07376 PRKG; protein kinase, cGMP-dependent [EC:2.7.11.12]
K07376 PRKG; protein kinase, cGMP-dependent [EC:2.7.11.12]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K00509 PTGS1; prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
K01832 TBXAS1; thromboxane-A synthase [EC:5.3.99.5]
K08508 SNAP23; synaptosomal-associated protein 23
K08512 VAMP8; vesicle-associated membrane protein 8
     04620 Toll-like receptor signaling pathway [PATH:ptr04620]
     04621 NOD-like receptor signaling pathway [PATH:ptr04621]
     04622 RIG-I-like receptor signaling pathway [PATH:ptr04622]
     04623 Cytosolic DNA-sensing pathway [PATH:ptr04623]
     04650 Natural killer cell mediated cytotoxicity [PATH:ptr04650]
     04612 Antigen processing and presentation [PATH:ptr04612]
     04660 T cell receptor signaling pathway [PATH:ptr04660]
     04662 B cell receptor signaling pathway [PATH:ptr04662]
     04664 Fc epsilon RI signaling pathway [PATH:ptr04664]
     04666 Fc gamma R-mediated phagocytosis [PATH:ptr04666]
     04670 Leukocyte transendothelial migration [PATH:ptr04670]
     04672 Intestinal immune network for IgA production [PATH:ptr04672]
     04062 Chemokine signaling pathway [PATH:ptr04062]
 
   Endocrine system
 
   Circulatory system
 
   Digestive system
 
   Excretory system
 
   Nervous system
     04724 Glutamatergic synapse [PATH:ptr04724]
     04727 GABAergic synapse [PATH:ptr04727]
     04725 Cholinergic synapse [PATH:ptr04725]
     04728 Dopaminergic synapse [PATH:ptr04728]
     04726 Serotonergic synapse [PATH:ptr04726]
       467070 TPH2; tryptophan hydroxylase 2
       466453 TPH1; tryptophan hydroxylase 1
       463409 DDC; dopa decarboxylase (aromatic L-amino acid decarboxylase)
       464032 SLC18A1; solute carrier family 18 (vesicular monoamine), member 1
       466213 SLC18A2; solute carrier family 18 (vesicular monoamine), member 2
       749637 SLC18A1; solute carrier family 18 (vesicular monoamine), member 1
       466914 CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit
       460447 CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit
       465629 CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit
       740711 voltage-dependent L-type calcium channel subunit alpha-1F-like
       469635 CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit
       467355 HTR2A; 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
       737647 HTR2B; 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled
       473740 HTR2C; 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
       472962 GNAQ; guanine nucleotide binding protein (G protein), q polypeptide
       453330 PLCB2; phospholipase C, beta 2
       458093 PLCB4; phospholipase C, beta 4
       469875 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific)
       451290 PLCB3; phospholipase C, beta 3 (phosphatidylinositol-specific)
       460134 ITPR1; inositol 1,4,5-trisphosphate receptor, type 1
       473389 ITPR2; inositol 1,4,5-trisphosphate receptor, type 2
       462618 ITPR3; inositol 1,4,5-trisphosphate receptor, type 3
       454832 PRKCA; protein kinase C, alpha
       456276 PRKCG; protein kinase C, gamma
       453993 PRKCB; protein kinase C, beta
       454037 MAPK3; mitogen-activated protein kinase 3
       458680 MAPK1; mitogen-activated protein kinase 1
       467664 PLA2G4E; phospholipase A2, group IVE
       469617 PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent)
       453706 cytosolic phospholipase A2 beta-like
       747584 PLA2G4B; phospholipase A2, group IVB (cytosolic)
       468935 PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent)
       100610135 PLA2G4D; phospholipase A2, group IVD (cytosolic)
       453356 PLA2G4F; phospholipase A2, group IVF
       739598 PLA2G4B; phospholipase A2, group IVB
       749457 PLA2G4B; phospholipase A2, group IVB
       739798 PLA2G4B; phospholipase A2, group IVB
       740368 PLA2G4B; phospholipase A2, group IVB
       748705 PLA2G4B; phospholipase A2, group IVB
       450909 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8
       100616515 cytochrome P450 2C9-like
       740956 cytochrome P450 2C19-like
       470228 CYP2D6; cytochrome P450, family 2, subfamily D, polypeptide 6 
       456896 cytochrome P450 2J2-like
       456833 cytochrome P450 4X1-like
       450428 ALOX5; arachidonate 5-lipoxygenase
       455242 ALOX12; arachidonate 12-lipoxygenase
       455243 arachidonate 12-lipoxygenase
       455103 ALOX12B; arachidonate 12-lipoxygenase, 12R type
       748294 ALOX15; arachidonate 15-lipoxygenase
       455104 ALOX15B; arachidonate 15-lipoxygenase, type B
       464713 PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
       469616 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
       451556 HTR3A; 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
       471023 HTR3E; 5-hydroxytryptamine (serotonin) receptor 3E, ionotropic
       471020 HTR3D; 5-hydroxytryptamine (serotonin) receptor 3 family member D
       471021 HTR3C; 5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
       466788 HTR3B; 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic
       462175 HTR4; 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
       469199 HTR6; 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled
       466154 HTR7; 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
       469986 GNAS; GNAS complex locus
       470905 ADCY5; adenylate cyclase 5
       469367 PRKACB; protein kinase, cAMP-dependent, catalytic, beta
       472944 PRKACG; protein kinase, cAMP-dependent, catalytic, gamma
       449495 PRKX; protein kinase, X-linked 
       455776 PRKACA; protein kinase, cAMP-dependent, catalytic, alpha
       751063 cAMP-dependent protein kinase catalytic subunit PRKX-like
       462006 KCNN2; potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
       472489 KCND2; potassium voltage-gated channel, Shal-related subfamily, member 2
       461352 GABRB1; gamma-aminobutyric acid (GABA) A receptor, beta 1
       453265 GABRB3; gamma-aminobutyric acid (GABA) A receptor, beta 3
       462240 GABRB2; gamma-aminobutyric acid (GABA) A receptor, beta 2
       467198 RAPGEF3; Rap guanine nucleotide exchange factor (GEF) 3
       473931 APP; amyloid beta (A4) precursor protein
       471533 HTR1A; 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
       462833 HTR1B; 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
       469219 HTR1D; 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
       470863 HTR1F; 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled
       472064 HTR1E; 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled
       463837 HTR5A; 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
       470518 5-hydroxytryptamine receptor 5B-like
       457093 GNAI3; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
       472425 GNAI1; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
       744773 GNAI2; guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
       450173 GNAO1; guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
       469458 GNB1; guanine nucleotide binding protein (G protein), beta polypeptide 1
       739897 GNB2; guanine nucleotide binding protein (G protein), beta polypeptide 2
       100612078 GNB3; guanine nucleotide binding protein (G protein), beta polypeptide 3
       460862 GNB4; guanine nucleotide binding protein (G protein), beta polypeptide 4
       745402 GNB5; guanine nucleotide binding protein (G protein), beta 5
       467457 GNG2; guanine nucleotide binding protein (G protein), gamma 2
       740869 GNG3; guanine nucleotide binding protein (G protein), gamma 3
       743331 GNG4; guanine nucleotide binding protein (G protein), gamma 4
       456977 GNG5; guanine nucleotide binding protein (G protein), gamma 5
       744391 GNG7; guanine nucleotide binding protein (G protein), gamma 7
       100608423 uncharacterized LOC100608423
       100611518 uncharacterized LOC100611518
       747185 GNG11; guanine nucleotide binding protein (G protein), gamma 11
       100609242 GNG12; guanine nucleotide binding protein (G protein), gamma 12
       468737 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like
       749882 GNG13; guanine nucleotide binding protein (G protein), gamma 13
       747170 GNGT1; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
       749133 GNGT2; guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
       461669 CASP3; caspase 3, apoptosis-related cysteine peptidase 
       466302 HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog
       473387 KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
       742713 NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog
       100614256 ARAF; v-raf murine sarcoma 3611 viral oncogene homolog
       463781 BRAF; v-raf murine sarcoma viral oncogene homolog B1
       460182 RAF1; v-raf-1 murine leukemia viral oncogene homolog 1
       450188 MAP2K1; mitogen-activated protein kinase kinase 1 
       455766 CACNA1A; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
       464893 CACNA1B; calcium channel, voltage-dependent, N type, alpha 1B subunit
       737029 KCNJ3; potassium inwardly-rectifying channel, subfamily J, member 3
       474111 KCNJ6; potassium inwardly-rectifying channel, subfamily J, member 6
       469548 KCNJ9; potassium inwardly-rectifying channel, subfamily J, member 9
       451660 KCNJ5; potassium inwardly-rectifying channel, subfamily J, member 5
       460747 TRPC1; transient receptor potential cation channel, subfamily C, member 1
       468201 SLC6A4; solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
       740491 MAOA; monoamine oxidase A
       465588 MAOB; monoamine oxidase B
       743285 amine oxidase [flavin-containing] A-like
K00502 TPH1_2; tryptophan 5-monooxygenase [EC:1.14.16.4]
K00502 TPH1_2; tryptophan 5-monooxygenase [EC:1.14.16.4]
K01593 DDC; aromatic-L-amino-acid decarboxylase [EC:4.1.1.28]
K08155 SLC18A1_2; MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K08155 SLC18A1_2; MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K08155 SLC18A1_2; MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K04850 CACNA1C; voltage-dependent calcium channel L type alpha-1C
K04851 CACNA1D; voltage-dependent calcium channel L type alpha-1D
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04853 CACNA1F; voltage-dependent calcium channel L type alpha-1F
K04857 CACNA1S; voltage-dependent calcium channel L type alpha-1S
K04157 HTR2; 5-hydroxytryptamine receptor 2
K04157 HTR2; 5-hydroxytryptamine receptor 2
K04157 HTR2; 5-hydroxytryptamine receptor 2
K04634 GNAQ; guanine nucleotide-binding protein G(q) subunit alpha
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K02677 CPKC; classical protein kinase C [EC:2.7.11.13]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 MAPK1_3; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K16342 PLA2G4; cytosolic phospholipase A2 [EC:3.1.1.4]
K17718 CYP2C8; cytochrome P450, family 2, subfamily C, polypeptide 8 [EC:1.14.14.1]
K17719 CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17721 CYP2C19; cytochrome P450, family 2, subfamily C, polypeptide 19 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
K17712 CYP2D6; cytochrome P450, family 2, subfamily D, polypeptide 6 [EC:1.14.14.1]
K07418 CYP2J; cytochrome P450, family 2, subfamily J [EC:1.14.14.1]
K07428 CYP4X; cytochrome P450, family 4, subfamily X [EC:1.14.14.1]
K00461 ALOX5; arachidonate 5-lipoxygenase [EC:1.13.11.34]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K00458 ALOX12; arachidonate 12-lipoxygenase [EC:1.13.11.31]
K08021 ALOX12B; arachidonate 12-lipoxygenase (R-type) [EC:1.13.11.-]
K00460 ALOX15; arachidonate 15-lipoxygenase [EC:1.13.11.33]
K08022 ALOX15B; arachidonate 15-lipoxygenase (second type) / 8-lipoxygenase (S-type) [EC:1.13.11.33 1.13.11.-]
K00509 PTGS1; prostaglandin-endoperoxide synthase 1 [EC:1.14.99.1]
K11987 PTGS2; prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04819 HTR3; 5-hydroxytryptamine receptor 3
K04160 HTR4; 5-hydroxytryptamine receptor 4
K04162 HTR6; 5-hydroxytryptamine receptor 6
K04163 HTR7; 5-hydroxytryptamine receptor 7
K04632 GNAS; guanine nucleotide-binding protein G(s) subunit alpha
K08045 ADCY5; adenylate cyclase 5 [EC:4.6.1.1]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04345 PKA; protein kinase A [EC:2.7.11.11]
K04943 KCNN2; potassium intermediate/small conductance calcium-activated channel subfamily N member 2
K04892 KCND2; potassium voltage-gated channel Shal-related subfamily D member 2
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K05181 GABRB; gamma-aminobutyric acid receptor subunit beta
K08014 RAPGEF3; Rap guanine nucleotide exchange factor 3
K04520 APP; amyloid beta A4 protein
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04153 HTR1; 5-hydroxytryptamine receptor 1
K04161 HTR5; 5-hydroxytryptamine receptor 5
K04161 HTR5; 5-hydroxytryptamine receptor 5
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04630 GNAI; guanine nucleotide-binding protein G(i) subunit alpha
K04534 GNAO; guanine nucleotide-binding protein G(o) subunit alpha
K04536 GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
K04537 GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2
K07825 GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3
K04538 GNB4; guanine nucleotide-binding protein subunit beta-4
K04539 GNB5; guanine nucleotide-binding protein subunit beta-5
K07826 GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
K04540 GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3
K04541 GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4
K04542 GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
K04543 GNG7; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
K04544 GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8
K04545 GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
K04546 GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04347 GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04547 GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
K04548 GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1
K04549 GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
K02187 CASP3; caspase 3 [EC:3.4.22.56]
K02833 HRAS; GTPase HRas
K07827 KRAS; GTPase KRas
K07828 NRAS; GTPase NRas
K08845 ARAF; A-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04365 BRAF; B-Raf proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04366 RAF1; RAF proto-oncogene serine/threonine-protein kinase [EC:2.7.11.1]
K04368 MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.12.2]
K04344 CACNA1A; voltage-dependent calcium channel P/Q type alpha-1A
K04849 CACNA1B; voltage-dependent calcium channel N type alpha-1B
K04997 KCNJ3; potassium inwardly-rectifying channel subfamily J member 3
K05000 KCNJ6; potassium inwardly-rectifying channel subfamily J member 6
K05002 KCNJ9; potassium inwardly-rectifying channel subfamily J member 9
K04999 KCNJ5; potassium inwardly-rectifying channel subfamily J member 5
K04964 TRPC1; transient receptor potential cation channel subfamily C member 1
K05037 SLC6A4; solute carrier family 6 (neurotransmitter transporter, serotonin) member 4
K00274 MAO; monoamine oxidase [EC:1.4.3.4]
K00274 MAO; monoamine oxidase [EC:1.4.3.4]
K00274 MAO; monoamine oxidase [EC:1.4.3.4]
     04720 Long-term potentiation [PATH:ptr04720]
     04730 Long-term depression [PATH:ptr04730]
     04723 Retrograde endocannabinoid signaling [PATH:ptr04723]
     04721 Synaptic vesicle cycle [PATH:ptr04721]
     04722 Neurotrophin signaling pathway [PATH:ptr04722]
 
   Sensory system
 
   Development
 
   Environmental adaptation
 
 Human Diseases

[ BRITE | KEGG2 | KEGG ]
Last updated: December 16, 2014